Capnocytophaga infections in humans are rare, especially in historically healthy individuals, but when it occurs, the disease can be deadly.

Vivesto AB, an oncology-focused development company, today announced that ethical approval has been obtained from the US Veterinary Review Board Clinical Studies Committee ...